双能金属伪影减少技术用于前列腺近距离治疗后植入后CT中碘-125粒子识别
研究评估双能CT高能虚拟单色图像(VMI)联合单能金属伪影减少(SEMAR)处理在前列腺近距离治疗后植入后CT中识别碘-125粒子的效果。对前列腺体模和6例临床病例行双能采集,回顾性重建65-200 keV VMI(有无SEMAR),用伪影指数评估金属伪影。结果显示高能级下 blooming 伪影减轻,SEMAR显著降低AI,有助于减少治疗计划剂量图中高剂量范围的过高估计;200 keV VMI联合SEMAR可清晰识别粒子位置和数量。
要点
- 高能级VMI可减轻碘-125粒子 blooming 伪影,200 keV联合SEMAR时粒子显示最清晰。
- SEMAR处理显著降低金属伪影指数(AI),减少治疗计划剂量图中高剂量范围的过高估计。
- 双能CT高能VMI联合SEMAR适用于碘-125前列腺近距离治疗植入后计划流程。
核心结论
- 在200 keV VMI联合SEMAR的治疗计划剂量分布图中,可清晰识别碘-125粒子的位置和数量。
研究设计与样本
- 对含模拟粒子的前列腺体模及6例接受碘-125前列腺近距离治疗的临床病例行快速管电压切换双能采集,回顾性重建65-200 keV VMI(有/无SEMAR),以半高全宽计算粒子口径评估粒子肿胀,用伪影指数(AI)评估金属伪影,并比较高低能VMI的剂量分布。
关键影像表现/征象
- 较高能级下 blooming 伪影减轻。
- SEMAR处理显著降低AI,有助于减少治疗计划剂量图中高剂量范围的过高估计。
临床应用与阅片要点
- 作者指出双能CT高能VMI联合SEMAR适用于碘-125前列腺近距离治疗植入后计划流程。
- 200 keV VMI联合SEMAR的治疗计划剂量分布图可清晰识别碘-125粒子的位置和数量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the metal artefact reductions of dual-energy CT high-energy virtual monochromatic images (VMI) combined with the Single-Energy Metal Artifact Reduction (SEMAR) (CANON MEDICAL SYSTEMS, Otawara, Japan) processing techniques for iodine (I)-125 seed identification in postimplant CT after prostate brachytherapy.
METHODS: Dual-energy acquisition with fast tube voltage switching was performed on a prostate phantom with simulated seeds and six clinical cases treated with I-125 prostate brachytherapy. The images were retrospectively reconstructed at VMI energy levels of 65-200 keV and with and without SEMAR (SEMAR and non-SEMAR images). To estimate seed swelling, the calibre of iodine-125 seed was calculated as the full width at half maximum. The metal artefacts were evaluated using the artefact index (AI). The dose distributions were calculated and were compared among the high-energy VMI (SEMAR and non-SEMAR images) and low-energy VMI (SEMAR images).
RESULTS: The blooming artefacts decreased at higher energy levels. In addition, the SEMAR process markedly reduced AI, which helped reduce overestimation of high dose ranges in the treatment planning dose map.
CONCLUSIONS: The locations and number of iodine-125 seed were clearly identified in the dose distribution map of the treatment planning using 200 keV VMI with SEMAR.
ADVANCES IN KNOWLEDGE: The high-energy VMI of the dual-energy CT in combination with SEMAR is appropriate for the postimplant planning process of I-125 prostate brachytherapy.
引用
- Suzuki C, Matsubara K, Ujihara Y, et al. Dual-energy metal artefact reduction for iodine-125 seed identification in postimplant CT after prostate brachytherapy. Br J Radiol. 2025. PMID: 39495147. doi:10.1093/bjr/tqae225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。